A significant shift in our drug policy has happened, as the government permit the availability of psilocybin mushrooms for therapeutic applications. Previously, these substances were heavily restricted, but a mounting body of evidence suggests they could offer benefits for mental health conditions like anxiety. This change represents a substantial